ReviewThe Lancet. Infectious diseases2023

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.

José Domínguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.